Keywords
Last Name
Institution

Alice C. Levine

TitlePROFESSOR
InstitutionMount Sinai
DepartmentEndocrinology, Diabetes and Bone Disease
Address5 East 98th Street
11th floor
New York NY 10029
Phone212-241-7975
Fax212-423-0508
    Other Positions
    TitleASSOCIATE PROFESSOR
    InstitutionMount Sinai
    DepartmentOncological Sciences


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Galati SJ, Hopkins SM, Cheesman KC, Zhuk RA, Levine AC. Primary aldosteronism: emerging trends. Trends Endocrinol Metab. 2013 Sep; 24(9):421-30.
      View in: PubMed
    2. Liu XH, Wu Y, Yao S, Levine AC, Kirschenbaum A, Collier L, Bauman WA, Cardozo CP. Androgens up-regulate transcription of the Notch inhibitor Numb in C2C12 myoblasts via Wnt/ß-catenin signaling to T cell factor elements in the Numb promoter. J Biol Chem. 2013 Jun 21; 288(25):17990-8.
      View in: PubMed
    3. Hatami R, Sieuwerts AM, Izadmehr S, Yao Z, Qiao RF, Papa L, Look MP, Smid M, Ohlssen J, Levine AC, Germain D, Burstein D, Kirschenbaum A, DiFeo A, Foekens JA, Narla G. KLF6-SV1 drives breast cancer metastasis and is associated with poor survival. Sci Transl Med. 2013 Jan 23; 5(169):169ra12.
      View in: PubMed
    4. Messer CK, Fowkes ME, Gabrilove JL, Post KD, Son H, Levine AC. ACTH-producing remnants following apoplexy of an ACTH-secreting pituitary macroadenoma. Pituitary. 2012 Dec; 15 Suppl 1:S6-9.
      View in: PubMed
    5. Brutsaert EF, Sasano H, Unger P, Beasley MB, Golden BK, Inabnet WB, Levine AC. Adrenal cortical carcinoma with late pulmonary metastases causing clinicical Cushing's syndrome: case report with immunohistochemical analysis of steriodogenic enzyme production. Endocr Pract. 2012 Nov-Dec; 18(6):e138-43.
      View in: PubMed
    6. Liu XH, Yao S, Levine AC, Kirschenbaum A, Pan J, Wu Y, Qin W, Collier L, Bauman WA, Cardozo CP. Nandrolone, an anabolic steroid, stabilizes Numb protein through inhibition of mdm2 in C2C12 myoblasts. J Androl. 2012 Nov-Dec; 33(6):1216-23.
      View in: PubMed
    7. Cannata DH, Kirschenbaum A, Levine AC. Androgen deprivation therapy as primary treatment for prostate cancer. J Clin Endocrinol Metab. 2012 Feb; 97(2):360-5.
      View in: PubMed
    8. Kirschenbaum A, Liu XH, Yao S, Leiter A, Levine AC. Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation. Ann N Y Acad Sci. 2011 Nov; 1237:64-70.
      View in: PubMed
    9. Liu XH, Yao S, Qiao RF, Levine AC, Kirschenbaum A, Pan J, Wu Y, Qin W, Bauman WA, Cardozo CP. Nandrolone reduces activation of Notch signaling in denervated muscle associated with increased Numb expression. Biochem Biophys Res Commun. 2011 Oct 14; 414(1):165-9.
      View in: PubMed
    10. Yang W, Levine AC. Androgens and prostate cancer bone metastases: effects on both the seed and the soil. Endocrinol Metab Clin North Am. 2011 Sep; 40(3):643-53, x.
      View in: PubMed
    11. Levine AC. Endocrinology and Metabolism Clinics of North America. Hormones and cancer: breast and prostate. Preface. Endocrinol Metab Clin North Am. 2011 Sep; 40(3):xvii-xviii.
      View in: PubMed
    12. Zaidi M, Sun L, Robinson LJ, Tourkova IL, Liu L, Wang Y, Zhu LL, Liu X, Li J, Peng Y, Yang G, Shi X, Levine A, Iqbal J, Yaroslavskiy BB, Isales C, Blair HC. ACTH protects against glucocorticoid-induced osteonecrosis of bone. Proc Natl Acad Sci U S A. 2010 May 11; 107(19):8782-7.
      View in: PubMed
    13. Liu XH, Kirschenbaum A, Weinstein BM, Zaidi M, Yao S, Levine AC. Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells. Biochem Biophys Res Commun. 2010 Apr 9; 394(3):715-20.
      View in: PubMed
    14. Xiong SD, Yu K, Liu XH, Yin LH, Kirschenbaum A, Yao S, Narla G, DiFeo A, Wu JB, Yuan Y, Ho SM, Lam YW, Levine AC. Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. Int J Cancer. 2009 Aug 15; 125(4):774-82.
      View in: PubMed
    15. Chen M, Tanner M, Levine AC, Levina E, Ohouo P, Buttyan R. Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells. Cell Cycle. 2009 Jan 1; 8(1):149-57.
      View in: PubMed
    16. Liu XH, Kirschenbaum A, Yao S, Levine AC. Androgens promote preosteoblast differentiation via activation of the canonical Wnt signaling pathway. Ann N Y Acad Sci. 2007 Nov; 1116:423-31.
      View in: PubMed
    17. Messer CK, Kirschenbaum A, New MI, Unger P, Gabrilove JL, Levine AC. Concomitant secretion of glucocorticoid, androgens, and mineralocorticoid by an adrenocortical carcinoma: case report and review of literature. Endocr Pract. 2007 Jul-Aug; 13(4):408-12.
      View in: PubMed
    18. Liu XH, Kirschenbaum A, Yao S, Liu G, Aaronson SA, Levine AC. Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells. Cancer Res. 2007 Jun 15; 67(12):5747-53.
      View in: PubMed
    19. DiFeo A, Narla G, Hirshfeld J, Camacho-Vanegas O, Narla J, Rose SL, Kalir T, Yao S, Levine A, Birrer MJ, Bonome T, Friedman SL, Buller RE, Martignetti JA. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. Clin Cancer Res. 2006 Jun 15; 12(12):3730-9.
      View in: PubMed
    20. Liu XH, Kirschenbaum A, Yao S, Levine AC. Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system. Ann N Y Acad Sci. 2006 Apr; 1068:225-33.
      View in: PubMed
    21. Liu XH, Kirschenbaum A, Yao S, Levine AC. The role of the interleukin-6/gp130 signaling pathway in bone metabolism. Vitam Horm. 2006; 74:341-55.
      View in: PubMed
    22. Kirschenbaum A, Liu XH, Yao S, Narla G, Friedman SL, Martignetti JA, Levine AC. Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones. Carcinogenesis. 2006 Feb; 27(2):216-24.
      View in: PubMed
    23. Narla G, DiFeo A, Yao S, Banno A, Hod E, Reeves HL, Qiao RF, Camacho-Vanegas O, Levine A, Kirschenbaum A, Chan AM, Friedman SL, Martignetti JA. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res. 2005 Jul 1; 65(13):5761-8.
      View in: PubMed
    24. Liu XH, Kirschenbaum A, Yao S, Levine AC. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. Endocrinology. 2005 Apr; 146(4):1991-8.
      View in: PubMed
    25. Liu XH, Kirschenbaum A, Yu K, Yao S, Levine AC. Cyclooxygenase-2 suppresses hypoxia-induced apoptosis via a combination of direct and indirect inhibition of p53 activity in a human prostate cancer cell line. J Biol Chem. 2005 Feb 4; 280(5):3817-23.
      View in: PubMed
    26. Liu XH, Kirschenbaum A, Lu M, Yao S, Dosoretz A, Holland JF, Levine AC. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line. J Biol Chem. 2002 Dec 20; 277(51):50081-6.
      View in: PubMed
    27. Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C, Holland JF, Levine AC. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. Biochem Biophys Res Commun. 2002 Jan 11; 290(1):249-55.
      View in: PubMed
    Levine's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067